company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 15:08:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 15:08:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,66696.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 15:08:44+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 15:08:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,66696.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 15:08:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-66696.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 15:08:44+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8499.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 15:08:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 15:08:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8499.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 15:08:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-75195.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 15:08:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 15:08:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-75195.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 15:08:44+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-193892.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 15:08:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-269087.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 15:08:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-269087.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 15:08:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13500000.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 15:08:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 15:08:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13500000.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 15:08:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 15:08:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15894604.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 15:08:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:27:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:27:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,66944.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:27:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,66944.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:27:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-66944.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:27:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,55587.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:27:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:27:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-55587.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:27:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-122531.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:27:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:27:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-122531.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:27:35+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,152482.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:27:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,29951.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:27:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,29951.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:27:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15790209.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:27:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:27:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15790209.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:27:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:27:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15790209.0
TherapeuticsMD Inc,TXMD,,0000025743,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:27:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,485856.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,485856.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,203756.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,203756.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,282100.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,985119.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,54711.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,13711.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1053541.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-771441.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2924.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2924.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-774365.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-774365.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-774365.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-774365.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,77400000.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,77400000.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,55710076.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q1,2011-01-01,2011-03-31,2012-05-11 16:58:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 15:08:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 15:08:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,58602.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 15:08:44+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 15:08:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,58602.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 15:08:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-58602.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 15:08:44+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3470.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 15:08:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5000.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 15:08:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1530.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 15:08:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-57072.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 15:08:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 15:08:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-57072.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 15:08:44+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 15:08:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-57072.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 15:08:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-57072.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 15:08:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,16575209.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 15:08:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 15:08:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,16575209.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 15:08:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 15:08:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,16575209.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 15:08:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:27:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2100.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:27:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2100.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:27:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2100.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:27:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,64594.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:27:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,64594.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:27:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-62494.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:27:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11732.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:27:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:27:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11732.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:27:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-74226.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:27:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4304.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:27:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-78530.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:27:35+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:27:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-78530.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:27:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-78530.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:27:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,16575209.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:27:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:27:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,16575209.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:27:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:27:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,16575209.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q3,2011-07-01,2011-09-30,2011-11-07 17:27:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1600221.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1600221.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,743356.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,743356.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,856865.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5297882.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,52530.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,41134.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5391546.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4534681.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7439178.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-33843.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7473021.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12007702.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-4304.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12003398.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12003398.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12003398.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,61500000.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.2
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,61500000.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.2
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,62516461.0
TherapeuticsMD Inc,TXMD,,0000025743,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.2
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,721692.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,721692.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,336124.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,336124.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,385568.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2827050.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,411961.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,14578.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3253589.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2868021.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10409837.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-11745.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10421582.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13289603.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13289603.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13289603.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13289603.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,83100000.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.16
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,83100000.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.16
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,84556216.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q1,2012-01-01,2012-03-31,2012-05-11 16:58:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 17:13:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,819150.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 17:13:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,819150.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 17:13:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,372370.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 17:13:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,372370.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 17:13:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,446780.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 17:13:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3573485.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 17:13:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,833342.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 17:13:44+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,14535.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 17:13:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4421362.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 17:13:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3974582.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 17:13:44+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1148761.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 17:13:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-6714950.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 17:13:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7863711.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 17:13:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11850038.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 17:13:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 17:13:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11850038.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 17:13:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11850038.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 17:13:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11850038.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 17:13:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,84600000.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 17:13:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 17:13:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,84600000.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 17:13:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 17:13:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,86149419.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 17:13:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 13:53:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1036456.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 13:53:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1036456.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 13:53:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,306843.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 13:53:05+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,306843.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 13:53:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,729613.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 13:53:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3291357.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 13:53:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1334005.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 13:53:05+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,14839.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 13:53:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4640201.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 13:53:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3910588.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 13:53:05+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,331858.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 13:53:05+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,932.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 13:53:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-330926.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 13:53:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4253259.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 13:53:05+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 13:53:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4253259.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 13:53:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4253259.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 13:53:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4253259.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 13:53:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,106300000.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 13:53:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 13:53:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,106300000.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 13:53:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 13:53:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,95895677.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 13:53:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1240715.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1240715.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,332776.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,332776.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,907939.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4377809.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1913054.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,12308.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6303171.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5395232.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,367853.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,12260.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-355593.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5727335.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5727335.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5727335.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5727335.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,92400000.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,92400000.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,91630693.0
TherapeuticsMD Inc,TXMD,,0000025743,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1537195.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1537195.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,380346.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,380346.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1156849.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4526582.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1565201.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,7957.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6099740.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4942891.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1165831.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-266931.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1432762.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6375653.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6375653.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6375653.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6375653.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,106300000.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,106300000.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,103052956.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:04:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:04:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2294720.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:04:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2294720.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:04:39+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,648403.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:04:39+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,648403.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:04:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1646317.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:04:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4752062.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:04:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4098903.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:04:39+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,32356.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:04:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8883321.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:04:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7237004.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:04:39+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:04:39+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:04:39+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-436004.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:04:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-436004.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:04:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7673008.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:04:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7673008.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:04:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7673008.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:04:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7673008.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:04:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,127900000.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:04:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:04:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,127900000.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:04:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:04:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,131212706.0
TherapeuticsMD Inc,TXMD,,0000025743,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:04:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 08:52:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2830533.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 08:52:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2830533.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 08:52:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,830707.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 08:52:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,830707.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 08:52:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1999826.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 08:52:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5029497.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 08:52:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5908078.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 08:52:47+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,13068.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 08:52:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10950643.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 08:52:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8950817.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 08:52:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,9154.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 08:52:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-241455.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 08:52:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-232301.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 08:52:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9183118.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 08:52:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9183118.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 08:52:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9183118.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 08:52:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9183118.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 08:52:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,153100000.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 08:52:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 08:52:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,153100000.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 08:52:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 08:52:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,145019561.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 08:52:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:49:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3751778.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:49:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3751778.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:49:18+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,892956.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:49:18+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,892956.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:49:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2858822.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:49:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5537164.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:49:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8234641.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:49:18+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,14094.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:49:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13785899.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:49:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10927077.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:49:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,9238.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:49:18+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,18579.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:49:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,27817.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:49:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10899260.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:49:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10899260.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:49:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10899260.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:49:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10899260.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:49:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,155700000.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:49:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:49:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,155700000.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:49:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:49:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,145485505.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:49:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:15:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4186261.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:15:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4186261.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:15:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1068605.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:15:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1068605.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:15:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3117656.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:15:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6043354.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:15:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14909430.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:15:49+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,12747.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:15:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20965531.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:15:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17847875.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:15:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,9364.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:15:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6260.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:15:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,15624.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:15:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17832251.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:15:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17832251.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:15:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17832251.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:15:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17832251.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:15:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,148600000.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:15:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:15:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,148600000.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:15:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:15:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,152200455.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:15:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4257647.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4257647.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,879535.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,879535.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3378112.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5514057.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14166789.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,12558.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19693404.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16315292.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,9553.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3158.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,12711.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16302581.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16302581.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16302581.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16302581.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,150600000.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,150600000.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,149727228.0
TherapeuticsMD Inc,TXMD,,0000025743,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4475049.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4475049.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1043641.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1043641.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3431408.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6163612.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18176835.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,13572.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24354019.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-20922611.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,18513.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,9842.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,28355.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-20894256.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20894256.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20894256.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-20894256.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,160700000.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,160700000.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,163448130.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 21:11:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4847934.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 21:11:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4847934.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 21:11:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1033089.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 21:11:14+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1033089.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 21:11:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3814845.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 21:11:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6865442.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 21:11:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24190714.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 21:11:14+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,14280.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 21:11:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,31070436.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 21:11:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-27255591.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 21:11:14+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-2560.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 21:11:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,25585.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 21:11:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,28145.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 21:11:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-27227446.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 21:11:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 21:11:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27227446.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 21:11:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27227446.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 21:11:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-27227446.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 21:11:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,170200000.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 21:11:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.16
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 21:11:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,170200000.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 21:11:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.16
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 21:11:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,172782264.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 21:11:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:37:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5190175.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:37:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5190175.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:37:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1193965.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:37:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1193965.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:37:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3996210.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:37:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7060944.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:37:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16421753.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:37:47+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,16548.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:37:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23499245.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:37:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19503035.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:37:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-2760.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:37:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,27630.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:37:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,30390.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:37:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19472645.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:37:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19472645.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:37:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19472645.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:37:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19472645.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:37:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,177000000.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:37:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:37:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,177000000.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:37:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:37:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,177206168.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 16:37:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5629740.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5629740.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1235978.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1235978.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4393762.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8631238.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13253472.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,18000.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21902710.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17508948.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-12122.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-18513.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,32662.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,26271.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17482677.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17482677.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17482677.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17482677.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,173600000.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,173600000.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,173174229.0
TherapeuticsMD Inc,TXMD,,0000025743,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4930091.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4930091.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1108443.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1108443.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3821648.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9678552.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15097017.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,19597.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24795166.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-20973518.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2536.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,41617.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,44153.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-20929365.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20929365.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20929365.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-20929365.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,190300000.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,190300000.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,194901560.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q1,2016-01-01,2016-03-31,2017-05-02 18:01:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:28:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4403247.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:28:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4403247.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:28:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1130108.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:28:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1130108.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:28:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3273139.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:28:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10619006.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:28:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13841193.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:28:04+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,24262.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:28:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24484461.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:28:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21211322.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:28:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2863.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:28:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,114320.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:28:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,117183.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:28:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21094139.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:28:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21094139.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:28:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21094139.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:28:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21094139.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:28:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,191800000.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:28:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:28:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,191800000.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:28:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:28:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,196325715.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 17:28:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 17:53:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5535685.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 17:53:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5535685.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 17:53:51+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1237446.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 17:53:51+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1237446.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 17:53:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4298239.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 17:53:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14721710.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 17:53:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14664123.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 17:53:51+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,40460.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 17:53:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,29426293.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 17:53:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25128054.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 17:53:51+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-2451.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 17:53:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,109942.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 17:53:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,112393.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 17:53:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-25015661.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 17:53:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25015661.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 17:53:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25015661.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 17:53:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-25015661.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 17:53:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,192400000.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 17:53:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 17:53:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,192400000.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 17:53:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 17:53:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,196502327.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 17:53:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4487427.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4487427.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,709711.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,709711.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3777716.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16329146.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10341144.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,48132.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26718422.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22940706.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-8373.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-5399.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,101438.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,104412.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22836294.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22836294.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22836294.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22836294.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,195400000.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,195400000.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,196088196.0
TherapeuticsMD Inc,TXMD,,0000025743,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3985464.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3985464.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,659635.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,659635.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3325829.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16837617.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7724840.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,49699.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24612156.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21286327.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-3867.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,125968.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,129835.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21156492.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21156492.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21156492.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21156492.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,192300000.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,192300000.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,197790040.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:35:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 06:04:38+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4250433.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 06:04:38+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4250433.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 06:04:38+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,681725.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 06:04:38+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,681725.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 06:04:38+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3568708.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 06:04:38+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14628927.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 06:04:38+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8716395.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 06:04:38+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,53189.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 06:04:38+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23398511.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 06:04:38+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19829803.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 06:04:38+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-3832.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 06:04:38+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,149054.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 06:04:38+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,152886.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 06:04:38+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19676917.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 06:04:38+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19676917.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 06:04:38+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19676917.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 06:04:38+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19676917.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 06:04:38+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,196800000.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 06:04:38+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 06:04:38+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,196800000.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 06:04:38+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 06:04:38+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,203384610.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 06:04:38+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 07:01:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4417598.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 07:01:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4417598.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 07:01:02+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,700814.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 07:01:02+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,700814.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 07:01:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3716784.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 07:01:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12057868.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 07:01:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6436802.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 07:01:02+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,54055.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 07:01:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18548725.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 07:01:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14831941.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 07:01:02+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,167300.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 07:01:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,167300.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 07:01:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14664641.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 07:01:02+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 07:01:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14664641.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 07:01:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14664641.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 07:01:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14664641.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 07:01:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,209500000.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 07:01:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 07:01:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,209500000.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 07:01:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 07:01:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,207938338.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 07:01:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4124218.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4124218.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,594769.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,594769.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3529449.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14178958.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10974956.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,56174.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25210088.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21680639.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,253309.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,253309.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21427330.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21427330.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21427330.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21427330.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,207900000.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,207900000.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,205523288.0
TherapeuticsMD Inc,TXMD,,0000025743,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3773392.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3773392.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,633623.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,633623.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3139769.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20757237.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7039297.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,59621.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27856155.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-24716386.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,314557.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,314557.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-24401829.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24401829.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24401829.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24401829.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,221800000.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,221800000.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,216525316.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 17:02:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 15:00:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3763010.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 15:00:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3763010.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 15:00:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,454161.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 15:00:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,454161.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 15:00:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3308849.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 15:00:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,29466770.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 15:00:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6798380.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 15:00:28+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,65603.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 15:00:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,36330753.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 15:00:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-33021904.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 15:00:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,531382.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 15:00:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,334238.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 15:00:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-197144.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 15:00:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-33219048.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 15:00:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33219048.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 15:00:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33219048.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 15:00:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-33219048.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 15:00:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,221500000.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 15:00:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 15:00:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,221500000.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 15:00:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 15:00:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,216640186.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 15:00:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 16:17:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3473535.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 16:17:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3473535.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 16:17:22+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,699118.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 16:17:22+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,699118.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 16:17:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2774417.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 16:17:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,30354072.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 16:17:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6708271.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 16:17:22+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,73321.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 16:17:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,37135664.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 16:17:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-34361247.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 16:17:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2053077.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 16:17:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,809022.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 16:17:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1244055.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 16:17:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-35605302.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 16:17:22+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 16:17:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-35605302.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 16:17:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-35605302.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 16:17:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-35605302.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 16:17:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,222500000.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 16:17:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.16
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 16:17:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,222500000.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 16:17:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.16
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 16:17:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,228107240.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 16:17:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5089523.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5089523.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,950750.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,950750.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4138773.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,35410875.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6753190.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,95341.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,42259406.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-38120633.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2093375.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,823027.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1270348.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-39390981.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-39390981.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-39390981.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-39390981.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,224800000.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,224800000.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,225026300.0
TherapeuticsMD Inc,TXMD,,0000025743,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.17
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3946651.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3946651.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,762827.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,762827.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3183824.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,34864082.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6317882.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,106938.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,41288902.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-38105078.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2090018.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,688721.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1401297.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-39506375.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-39506375.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-39506375.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-39506375.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,246900000.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.16
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,246900000.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.16
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,241006032.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:23:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 15:00:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6078865.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 15:00:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6078865.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 15:00:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1248860.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 15:00:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1248860.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 15:00:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4830005.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 15:00:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,41387451.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 15:00:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4964368.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 15:00:28+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,115059.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 15:00:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,46466878.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 15:00:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-41636873.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 15:00:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,14086241.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 15:00:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,486597.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 15:00:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-13599644.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 15:00:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-55236517.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 15:00:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-55236517.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 15:00:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-55236517.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 15:00:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-55236517.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 15:00:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,240200000.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 15:00:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 15:00:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,240200000.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 15:00:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 15:00:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,241221840.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 15:00:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 16:17:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23719741.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 16:17:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23719741.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 16:17:22+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1444308.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 16:17:22+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1444308.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 16:17:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,22275433.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 16:17:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,45126986.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 16:17:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4077738.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 16:17:22+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,141959.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 16:17:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,49346683.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 16:17:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-27071250.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 16:17:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5599005.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 16:17:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,703662.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 16:17:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4895343.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 16:17:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-31966593.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 16:17:22+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 16:17:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31966593.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 16:17:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31966593.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 16:17:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-31966593.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 16:17:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,245900000.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 16:17:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 16:17:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,245900000.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 16:17:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 16:17:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,241261299.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 16:17:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15901680.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15901680.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2878590.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2878590.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13023090.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,52734093.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4432224.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,248830.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,57415147.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-44392057.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5664583.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,621126.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5043457.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-49435514.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-49435514.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-49435514.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-49435514.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,244600000.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.2
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,244600000.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.2
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,246353318.0
TherapeuticsMD Inc,TXMD,,0000025743,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.2
